The use of prefilled saline syringes significantly lowers the likelihood of medical errors and decreases contamination risks, making them an essential component in modern healthcare practices. By providing a ready-to-use solution that eliminates the need for manual preparation, these syringes enhance the overall safety and efficiency of medical procedures. Healthcare professionals benefit from the convenience of prefilled syringes, which streamline the process of administering saline, particularly in high-pressure environments such as hospitals and emergency settings. The reduction in steps associated with manual filling not only minimizes the chances of dosage errors but also helps prevent cross-contamination that may occur when using multi-dose vials. As a result, prefilled saline syringes contribute to improved patient outcomes and higher standards of care, reinforcing their adoption among healthcare providers. This increased focus on safety and efficiency drives demand for prefilled saline syringes in the market, positioning them as a key factor in the ongoing evolution of medical device offerings.
Access Full Report @ https://www.databridgemarketresearch.com/fr/reports/emea-prefilled-syringes-market
Data Bridge Market Research analyzes that the EMEA Prefilled Syringes (Saline) Market size was valued at USD 154.31 million in 2023 and is projected to reach USD 314.52 million by 2031, with a CAGR of 9.6% during the forecast period of 2024 to 2031.
Key Findings of the Study
Rise in Nosocomial Infections
The rise in nosocomial infections presents a significant opportunity for the growth of prefilled saline syringes in the healthcare market. Traditional pouched saline can contribute to nosocomial infections due to contamination risks during preparation and handling. As hospitals and healthcare facilities increasingly grapple with the challenges posed by hospital-acquired infections, there is a heightened focus on implementing strategies that enhance patient safety and reduce infection risks. Prefilled saline syringes offer a compelling solution in this context, as they minimize the handling of sterile solutions and reduce the potential for contamination during the preparation and administration of intravenous therapies. By utilizing prefilled syringes, healthcare providers streamlines their processes, eliminating unnecessary steps that may introduce pathogens into sterile environments. This is particularly crucial in settings such as intensive care units and surgical wards, where vulnerable patients are at an elevated risk for infections. Furthermore, the consistent quality and sterility of commercially available prefilled saline syringes align with infection control protocols, making them a preferred choice for flushing intravenous lines and maintaining catheter patency. As awareness of infection prevention grows among healthcare professionals and administrators, the demand for prefilled saline syringes is likely to increase, as they represent a proactive approach to reducing nosocomial infections.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2024 to 2031
|
|
Base Year
|
2023
|
|
Historic Year
|
2022 (Customizable 2016-2021)
|
|
Quantitative Units
|
Revenue in USD Million
|
|
Segments Covered
|
Product (Plastic (Polymer) Prefilled Syringes and Glass Prefilled Syringes), Capacity (5 ML, 10 ML, 20 ML and Others), Packaging (100/Box, 120/Box, 60/Box and Others), Application (Cancer, Diabetes, Multiple Sclerosis, Thrombosis, Ophthalmology, Rheumatoid Arthritis, Anaphylaxis, Vaccines, and Others), End User (Healthcare Facilities, Home Healthcare Settings, Mail Order Pharmacy, Pharmaceutical and Biotechnology Companies, and Others)
|
|
Countries Covered
|
Germany, France, U.K., Italy, Spain, Russia, Netherlands, Switzerland, Turkey, Belgium, Denmark, Sweden, Poland, Norway, Finland, rest of Europe, South Africa, Saudi Arabia, U.A.E., Bahrain, Kuwait, Oman, Qatar, Egypt, Israel, and rest of Middle East and Africa
|
|
Market Players Covered
|
B. Braun SE (Germany), BD (U.S.), MedXL Inc. (Netherlands), STI Group (Netherlands), Guerbet (France), Terumo Corporation (Japan), Fresenius Kabi AG (Germany), Polymedicure (India), AGUETTANT (France), Anhui Tiankang Medical Technology Co., Ltd. (China), Weigao Medical International Co., Ltd (China), Medline Industries, LP (U.S.), and Nipro Medical Corporation (Japan) among others
|
|
Data Points Covered in the Report
|
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Segment Analysis
EMEA prefilled syringes (saline) market is segmented into five notable segments based on product, capacity, packaging, application, and end user.
- On the basis of product, the EMEA prefilled syringes (saline) market is segmented into plastic (polymer) prefilled syringes and glass prefilled syringes
In 2024, the plastic (polymer) prefilled syringes segment is expected to dominate the EMEA prefilled syringes (saline) market
In 2024, the plastic (polymer) prefilled syringes segment is expected to dominate the market with a market share of 86.14% due to their cost-effectiveness, break resistance, and compatibility with biologics.
- On the basis of capacity, the EMEA prefilled syringes (saline) market is segmented into 10 ml, 5 ml, 20 ml, and others
In 2024, the 10 ml segment is expected to dominate the EMEA prefilled syringes (saline) market
In 2024, 10 ml segment is expected to dominate the market with a market share of43.54% due to its versatility for various applications, including larger-volume drug deliveries and hydration therapies.
- On the basis of packaging, the EMEA prefilled syringes (saline) market is segmented into 100/Box, 120/Box, 60/Box, and others. In 2024, 100/Box segment is expected to dominate the market with a market share of 39.24%
- On the basis of application, the EMEA prefilled syringes (saline) market is segmented into cancer, diabetes, multiple sclerosis, thrombosis, ophthalmology, rheumatoid arthritis, anaphylaxis, vaccines, and others In 2024, cancer segment is expected to dominate the market with a market share of 26.75%
- On the basis of end user, the EMEA prefilled syringes (saline) market is segmented into healthcare facilities, home healthcare settings, mail order pharmacy, pharmaceutical and biotechnology companies and others. In 2024, healthcare facilities segment is expected to dominate the market with a market share of 35.43%
Major Players
B. Braun SE (Germany), BD (U.S.), MedXL Inc. (Netherlands), and STI Group (Netherlands) among others as the major market players of the market.
Market Developments
- In March 2022, B. Braun has divested its Colombian provider business as part of a strategic decision to streamline operations and focus on core markets. This move allows the company to allocate resources more effectively, enhance operational efficiency, and strengthen its presence in key regions, ultimately supporting its long-term growth objectives
- In October 2024, BD and Ypsomed are collaborating to enhance self-injection systems for high-viscosity biologics, aiming to improve patient experience and accessibility for medications requiring complex delivery methods
- In October 2024, BD has launched a new robotics solution to automate and standardize single-cell research, enhancing efficiency and accuracy in the analysis of cellular behavior and interactions for advanced scientific studies
- In November 2023, Medline Industries, LP revealed a multi-year prime vendor distribution agreement with University of Utah Health, ensuring a steady supply of essential medical supplies for the Mountain West region. This partnership enhanced operational efficiencies and was supported by Medline's new Salt Lake City distribution center
- In April 2022, Terumo Corporation rebranded its “General Hospital Company” to “Medical Care Solutions Company,” effective April 1, 2022. This change supported Terumo’s 5-Year Growth Strategy (GS26) amidst a shift towards home care and personalized treatment. The new brand, Terumo Medical Care Solutions (TMCS), reflected the company’s commitment to enhancing healthcare efficiency and safety, leveraging its century-long expertise in medical products and expanding into diabetes treatment and drug delivery technologies
Regional Analysis
Geographically, the countries covered in the EMEA prefilled syringes (saline) market report are the Germany, France, U.K., Italy, Spain, Russia, Netherlands, Switzerland, Turkey, Belgium, Denmark, Sweden, Poland, Norway, Finland, rest of Europe, South Africa, Saudi Arabia, U.A.E., Bahrain, Kuwait, Oman, Qatar, Egypt, Israel, and rest of Middle East and Africa.
As per Data Bridge Market Research analysis:
Europe region is expected to dominate the EMEA prefilled syringes (saline) market
Europe region is expected to dominate the market due to its advanced healthcare infrastructure, high adoption of innovative medical technologies, and increasing emphasis on patient-centric care, which drives demand for effective and reliable intravenous access solutions.
For more detailed information about the EMEA prefilled syringes (saline) market report, click here – https://www.databridgemarketresearch.com/fr/reports/emea-prefilled-syringes-market
